Wellth secures $36mn in oversubscribed Series C as health plans turn to daily care motivation

Wellth has raised $36 million in an oversubscribed Series C financing round, underscoring strong investor appetite for digital health models that can prove measurable improvements in outcomes. The funding round, initially closed in March 2025, was extended as demand exceeded expectations. The Los Angeles-based company has carved out a niche with what it calls Daily Care Motivation, a behaviorally driven approach designed to help high-risk populations stick with treatment and reduce costs for health plans.

The round was led by Mercato Partners, joined by FCA Venture Partners, Comcast Ventures, and existing investors SignalFire, New York Life, and CD-Venture. The new capital will allow Wellth to expand its platform across Medicare Advantage, Medicaid, and Dual-Eligible Special Needs Plans, while investing in generative AI technology to further personalize patient engagement.

Why did investors oversubscribe Wellth’s Series C and what does this signal about digital health funding trends?

Investor enthusiasm for Wellth comes against a backdrop of more cautious funding across the digital health sector. After the pandemic-era surge in telehealth valuations, many companies faced a sharp correction. Venture capitalists who once backed every platform promising engagement or virtual visits are now pressing for evidence of financial sustainability and clinical outcomes. In that climate, Wellth’s oversubscribed round stands out.

The core differentiator lies in the company’s proof of results. Health plans have reported measurable reductions in costs and improvements in outcomes when using Wellth’s app with high-risk populations. By leveraging behavioral economics and small financial incentives, Wellth has created a system in which patients are rewarded for consistency rather than penalized for lapses. This positive reinforcement model aligns closely with how habits form in real life.

The participation of long-term investors like SignalFire and New York Life alongside new backers like Mercato Partners suggests institutional confidence in the scalability of this model. Analysts note that oversubscription also indicates broader momentum: investors see Wellth as part of a second wave of digital health, where emphasis is shifting from volume-driven adoption to outcome-driven value.

How does Wellth’s daily care motivation approach create measurable differences from traditional patient engagement programs?

Traditional patient engagement often relies on reminders sent via text, phone calls, or email. While well-intentioned, these sporadic interactions tend to be ignored or treated as background noise. Wellth takes a different route. Over the past 11 years, it has built a model around consistent, daily micro-engagements. Patients check in through the app to confirm medication adherence, submit blood pressure readings, or log glucose levels. In exchange, they receive financial incentives that reinforce the habit.

The result is a sense of daily accountability that feels less like a nag and more like encouragement. This dynamic is particularly powerful for populations that are historically hard to reach, such as Medicaid members juggling multiple social challenges. Wellth’s interface, which mimics the familiar design of social media feeds, creates a sense of continuity and routine.

Matthew Loper, CEO and co-founder, has argued that the system reflects how people actually live. Instead of relying on healthcare workers to interrupt lives with occasional outreach, Wellth embeds motivation into daily routines. John Snyder, now the company’s COO, explained that he chose to join Wellth after seeing the platform outperform decades of traditional approaches to behavior change in healthcare. His perspective reflects a growing recognition among executives that consistent, low-friction engagement is more effective than occasional high-touch interventions.

How will Wellth use its $36M funding to expand access, scale partnerships, and introduce generative AI personalization?

The Series C funds will primarily support scaling across Medicare Advantage and Medicaid populations. These programs, which together cover tens of millions of Americans, are under enormous financial pressure from rising chronic disease rates and hospital costs. Health plans are increasingly motivated to adopt solutions that improve adherence to treatment and help members avoid costly emergency interventions. Wellth’s model aligns with this incentive structure, making it an attractive partner.

Equally important is the company’s investment in technology. With more than a decade of behavioral and health outcomes data, Wellth plans to integrate generative AI to personalize engagement. This next evolution will allow the platform to tailor motivational nudges at the individual level. For example, one patient may respond better to positive reinforcement about medication adherence, while another may need cost-saving reminders tied to avoiding complications.

By embedding AI-driven personalization, Wellth hopes to deliver a level of engagement comparable to consumer platforms while targeting clinical outcomes. This ambition reflects a broader healthcare trend: using data and machine learning to refine interventions without overwhelming already stretched clinical staff. If successful, Wellth could provide health plans with a turnkey solution that drives measurable cost savings at scale.

What does Wellth’s trajectory reveal about consolidation trends and the future direction of healthcare innovation?

Wellth’s rapid growth raises questions about whether it could become an acquisition target. Larger insurers and diversified healthcare providers are actively buying digital engagement platforms to integrate with broader population health strategies. Recent acquisitions by CVS Health and UnitedHealth illustrate how payers are consolidating tools that deliver measurable outcomes.

While Wellth has emphasized organic growth for now, its rich dataset, established payer relationships, and evidence-based ROI make it attractive to potential buyers. Market observers suggest that if Wellth can continue scaling, it may draw acquisition interest not only from insurers but also from pharmacy benefit managers and technology giants eager to enter healthcare.

At the same time, its Series C shows how investors are recalibrating expectations. The days of backing untested engagement ideas have passed. What institutions want now is proof—proof that patient behavior can change and that such change translates into avoided costs. Wellth offers both, positioning it as part of the future of healthcare innovation.

For the industry at large, the company’s success reinforces a key shift. Digital health is no longer just about virtual visits or apps that track symptoms. It is about embedding daily behaviors into routines, leveraging behavioral science, and creating measurable value for payers. In that sense, Wellth’s trajectory provides a glimpse of where healthcare innovation may head in the next decade.